Literature DB >> 3339799

Cigarette smoking as a risk factor for stroke. The Framingham Study.

P A Wolf1, R B D'Agostino, W B Kannel, R Bonita, A J Belanger.   

Abstract

The impact of cigarette smoking on stroke incidence was assessed in the Framingham Heart Study cohort of 4255 men and women who were aged 36 to 68 years and free of stroke and transient ischemic attacks. During 26 years of follow-up, 459 strokes occurred. Regardless of smoking status and in each sex, hypertensive subjects had twice the incidence of stroke. Using the Cox proportional hazard regression method, smoking was significantly related to stroke after age and hypertension were taken into account. Even after pertinent cardiovascular disease risk factors were added to the Cox model, cigarette smoking continued to make a significant independent contribution to the risk of stroke generally and brain infarction specifically. The risk of stroke increased as the number of cigarettes smoked increased. The relative risk of stroke in heavy smokers (greater than 40 cigarettes per day) was twice that of light smokers (fewer than ten cigarettes per day). Lapsed smokers developed stroke at the same level as nonsmokers soon after stopping. Stroke risk decreased significantly by two years and was at the level of nonsmokers by five years after cessation of cigarette smoking.

Entities:  

Mesh:

Year:  1988        PMID: 3339799

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  128 in total

Review 1.  Transient ischaemic attacks : new approaches to management.

Authors:  Ramesh Madhavan; Seemant Chaturvedi
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events?

Authors:  G J Hankey; J M Slattery; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

3.  Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial.

Authors:  Alan R Lifson; Jacqueline Neuhaus; Jose Ramon Arribas; Mary van den Berg-Wolf; Ann M Labriola; Timothy R H Read
Journal:  Am J Public Health       Date:  2010-08-19       Impact factor: 9.308

4.  Different risk factor profiles between subtypes of ischemic stroke. A case-control study in Korean men.

Authors:  Yun-Mi Song; Sun Uck Kwon; Joohon Sung; Shah Ebrahim; George Davey Smith; Sung Sunwoo; Yeong Sook Yun
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 5.  Peripheral and cerebral atherothrombosis and cardiovascular events in different vascular territories: insights from the Framingham Study.

Authors:  William B Kannel; Philip A Wolf
Journal:  Curr Atheroscler Rep       Date:  2006-07       Impact factor: 5.113

6.  Increased risk of stroke among patients with ankylosing spondylitis: a population-based matched-cohort study.

Authors:  Joseph J Keller; Jung-Lung Hsu; Shiue-Ming Lin; Chia-Chi Chou; Li-Hsuan Wang; Jui Wang; Chyi-Huey Bai; Hung-Yi Chiou
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

7.  Association of CYP1A1 Gene Polymorphism with Ischemic Stroke in South Indian Population.

Authors:  Shehnaz Sultana; Venkata Karunakar Kolla; Vidyullatha Peddireddy; Yasovanthi Jeedigunta; Pranay K Penagaluru; Sindhu Joshi; Usha Rani Penagaluru; Pardhananda Reddy Penagaluru
Journal:  Transl Stroke Res       Date:  2011-01-20       Impact factor: 6.829

8.  Smoking and mortality in stroke survivors: can we eliminate the paradox?

Authors:  Deborah A Levine; James M Walter; Sudeep J Karve; Lesli E Skolarus; Steven R Levine; Kristine A Mulhorn
Journal:  J Stroke Cerebrovasc Dis       Date:  2014-01-15       Impact factor: 2.136

9.  Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.

Authors:  O Lidegaard
Journal:  BMJ       Date:  1993-04-10

10.  Predictors of stroke mortality in elderly people from the general population. The CArdiovascular STudy in the ELderly.

Authors:  A Mazza; A C Pessina; A Pavei; R Scarpa; V Tikhonoff; E Casiglia
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.